1. Madigan JB, Ratnam LA, Belli AM. Arterial closure devices. A review. J Cardiovasc Surg (Torino). 2007. 48:607–624.
2. Bent CL, Kyriakides C, Matson M. Femoral artery stenosis following percutaneous closure using a starclose closure device. Cardiovasc Intervent Radiol. 2008. 31:814–816.
3. Brueck M, Bandorski D, Rauber K, Boening A. Percutaneous transluminal dilatation of inadvertent partial or complete occlusion of the femoral artery caused by Angio-Seal deployment for puncture site closure after cardiac catheterization. J Invasive Cardiol. 2010. 22:353–357.
4. Cooper CL, Miller A. Infectious complications related to the use of the angio-seal hemostatic puncture closure device. Catheter Cardiovasc Interv. 1999. 48:301–303.
5. Jang JJ, Kim M, Gray B, Bacharach JM, Olin JW. Claudication secondary to Perclose use after percutaneous procedures. Catheter Cardiovasc Interv. 2006. 67:687–695.
6. Kim YJ, Yoon HK, Ko GY, Shin JH, Sung KB. Percutaneous transluminal angioplasty of suture-mediated closure device-related femoral artery stenosis or occlusive disease. Br J Radiol. 2009. 82:486–490.
7. Stone PA, Campbell JE, Andrews KH, Bates MC. Posterior wall capture and resultant common femoral occlusion complicating StarClose access closure. J Vasc Surg. 2008. 48:469–471.
8. Dangas G, Mehran R, Kokolis S, Feldman D, Satler LF, Pichard AD, et al. Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. J Am Coll Cardiol. 2001. 38:638–641.
9. Koreny M, Riedmuller E, Nikfardjam M, Siostrzonek P, Mullner M. Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis. JAMA. 2004. 291:350–357.
10. Chamberlin JR, Lardi AB, McKeever LS, Wang MH, Ramadurai G, Grunenwald P, et al. Use of vascular sealing devices (VasoSeal and Perclose) versus assisted manual compression (Femostop) in transcatheter coronary interventions requiring abciximab (ReoPro). Catheter Cardiovasc Interv. 1999. 47:143–147. discussion 148.
11. Jaspers L, Benit E. Immediate sheath removal after PCI using a Femostop is feasible and safe. Results of a registry. Acta Cardiol. 2003. 58:535–537.
12. Juergens CP, Leung DY, Crozier JA, Wong AM, Robinson JT, Lo S, et al. Patient tolerance and resource utilization associated with an arterial closure versus an external compression device after percutaneous coronary intervention. Catheter Cardiovasc Interv. 2004. 63:166–170.
13. Kunert M, Gremmler B, Schleiting H, Ulbricht LJ. Use of FemoStop system for arterial puncture site closure after coronary angioplasty. J Invasive Cardiol. 2004. 16:240–242.
14. Brown DB, Gould JE, Gervais DA, Goldberg SN, Murthy R, Millward SF, et al. Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol. 2009. 20:S425–S434.
15. Walker SB, Cleary S, Higgins M. Comparison of the FemoStop device and manual pressure in reducing groin puncture site complications following coronary angioplasty and coronary stent placement. Int J Nurs Pract. 2001. 7:366–375.
16. Khaghany K, Al-Ali F, Spigelmoyer T, Pimentel R, Wharton K. Efficacy and safety of the perclose closer s device after neurointerventional procedures: prospective study and literature review. AJNR Am J Neuroradiol. 2005. 26:1420–1424.
17. Assali AR, Sdringola S, Moustapha A, Ghani M, Salloum J, Schroth G, et al. Outcome of access site in patients treated with platelet glycoprotein IIb/IIIa inhibitors in the era of closure devices. Catheter Cardiovasc Interv. 2003. 58:1–5.
18. Warren BS, Warren SG, Miller SD. Predictors of complications and learning curve using the Angio-Seal closure device following interventional and diagnostic catheterization. Catheter Cardiovasc Interv. 1999. 48:162–166.
19. Balzer JO, Scheinert D, Diebold T, Haufe M, Vogl TJ, Biamino G. Postinterventional transcutaneous suture of femoral artery access sites in patients with peripheral arterial occlusive disease: a study of 930 patients. Catheter Cardiovasc Interv. 2001. 53:174–181.
20. Dauerman HL, Applegate RJ, Cohen DJ. Vascular closure devices: the second decade. J Am Coll Cardiol. 2007. 50:1617–1626.
21. Kim HY, Choo SW, Roh HG, Han H, Kim SS, Lee JY, et al. Efficacy of femoral vascular closure devices in patients treated with anticoagulant, abciximab or thrombolytics during percutaneous endovascular procedures. Korean J Radiol. 2006. 7:35–40.
22. Wada H, Usui M, Sakuragawa N. Hemostatic abnormalities and liver diseases. Semin Thromb Hemost. 2008. 34:772–778.